Outcomes and Predictors of Mortality Among Octogenarians and Older With ST-Segment Elevation Myocardial Infarction Treated With Primary Coronary Angioplasty

被引:22
|
作者
Caretta, Giorgio [1 ]
Passamonti, Enrico [1 ]
Pedroni, Paolo Nicola [1 ]
Fadin, Bianca Maria [1 ]
Galeazzi, Gian Luca [1 ]
Pirelli, Salvatore [1 ]
机构
[1] AO Ist Ospitalieri Cremona, Dept Cardiol, I-26100 Cremona, Italy
关键词
GREATER-THAN-OR-EQUAL-TO-85; YEARS; AGE; REPERFUSION; INTERVENTION; TRIAL; THERAPY; IMPACT; CARE;
D O I
10.1002/clc.22313
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Elderly patients are at high risk of mortality when they present with ST-elevation myocardial infarction (STEMI). However, few data exist about prognostic factors in this sub-group when treated with primary percutaneous coronary intervention (pPCI). Hypothesis: To assess outcome and predictors of mortality among patients aged >80 years treated with pPCI. Methods: We evaluated 139 consecutive patients (age 85.1 +/- 3.9 years, 43.2% males) who underwent pPCI for STEMI. Results: Male patients were younger and were more likely to have a history of coronary artery disease. Overall 30-day and 1-year mortality rates were 20.9% and 28.1%, respectively. Thrombolysis in Myocardial Infarction (TIMI) flow 3 was achieved in 82% of patients. There was a pPCI success rate in male patients. At univariable analysis, older age, diabetes mellitus, Killip class >III, left ventricular ejection fraction (LVEF) <40%, no use of stent, failure of pPCI, systolic blood pressure (SBP) <100 mm Hg, and infarct-related artery (left anterior descending vs others) were associated with higher 1-year mortality. Multivariate analysis identified LVEF <40% (hazard ratio: [HR] = 3.70; 95% confidence interval [CI]: 1.30-7.87; P = 0.0001), age (1-year step, HR: 1.13; 95% CI: 1.04-1.23; P = 0.007), failure of pPCI (HR: 2.93; 95% CI: 1.44-5.98; P = 0.0001), Killip class = III (HR: 2.29; 95% CI: 1.03-5.4; P = 0.04) and SBP <100 mm Hg (HR: 2.64; 95% CI: 1.22-5.19; P = 0.01) to be independently associated with increased 1-year mortality. Conclusions: Our data show that elderly patients with STEMI have a high risk of mortality, which is particularly high in the first 30 days. Older age, LVEF <40% at admission, hemodynamic instability (higher Killip class or low SBP), and postinterventional TIMI flow <3 were independent predictors of mortality in our population.
引用
收藏
页码:523 / 529
页数:7
相关论文
共 50 条
  • [1] Outcomes of Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction in Octogenarians
    Jan, Fuad
    Hafiz, Abdul-Moiz
    Mori, Naoyo
    Gupta, Anjan
    Bajwa, Tanvir
    Allaqaband, Suhail
    CIRCULATION, 2009, 120 (18) : S986 - S986
  • [2] Predictors of no-reflow in patients with myocardial infarction and ST-segment elevation treated with primary angioplasty
    Cordero, A.
    Escribano, D.
    Monteagudo, M.
    Zuazola, P.
    Frutos, A.
    Bertomeu-Gonzalez, V.
    EUROPEAN HEART JOURNAL, 2022, 43 : 2062 - 2062
  • [3] Predictors of contrast nephropathy in patients with ST-segment elevation myocardial infarction treated with primary angioplasty
    Papaioannou, G. I.
    Athar, H.
    Dada, M. R.
    Patel, S. B.
    Deliargyris, E. N.
    Boden, W. E.
    Kiernan, F. J.
    McKay, R. G.
    EUROPEAN HEART JOURNAL, 2005, 26 : 426 - 427
  • [4] Age, myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty
    De Luca, G
    Suryapranata, H
    Ottervanger, JP
    De Boer, MJ
    Hoorntje, JCA
    Gosselink, ATM
    Dambrink, JHE
    Van't Hof, AWJ
    EUROPEAN HEART JOURNAL, 2004, 25 : 359 - 359
  • [5] Symptom onset to balloon time in patients with ST-segment elevation myocardial infarction treated by primary coronary angioplasty: influence on ST-segment resolution and on mortality
    E Abu Assi
    R Vidal Perez
    F Soto Loureiro
    E Paredes Galan
    A Amaro Cendon
    Critical Care, 11 (Suppl 2):
  • [6] Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty
    De Luca, G
    Suryapranata, H
    van't Hof, AW
    Ottervanger, JP
    Hoorntje, JCA
    Gosselink, ATM
    Dambrink, JHE
    de Boer, MJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 192A - 193A
  • [7] Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty
    De Luca, G
    van't Hof, AWJ
    Ottervanger, JP
    Hoorntje, JCA
    Gosselink, ATM
    Dambrink, JHE
    de Boer, MJ
    Suryapranata, H
    EUROPEAN HEART JOURNAL, 2005, 26 (07) : 662 - 666
  • [8] Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty
    De Luca, G
    Suryapranata, H
    Ottervanger, JP
    van't Hof, AWJ
    Hoorntje, JCA
    Gosselink, ATM
    Dambrink, JHE
    Zijistra, F
    de Boer, MJ
    AMERICAN HEART JOURNAL, 2005, 150 (06) : 1185 - 1189
  • [9] Unsuccessful reperfusion in patients with ST-segment elevation myocardial infarction treated by primary angioplasty
    De Luca, G
    van't Hof, AWJ
    Ottervanger, JP
    Hoorntje, JCA
    Gosselink, ATM
    Dambrink, JHE
    Zijlstra, F
    de Boer, MJ
    Suryapranata, H
    AMERICAN HEART JOURNAL, 2005, 150 (03) : 557 - 562
  • [10] Early outcome and prognostic factors among elderly patients with ST-segment elevation myocardial infarction treated with primary coronary angioplasty
    Caretta, G.
    Passamonti, E.
    Pedroni, P. N.
    Fadin, B. M.
    Pirelli, S.
    EUROPEAN HEART JOURNAL, 2012, 33 : 465 - 465